MeiraGTx Holdings plc SEC filings MGTX

MeiraGTx Holdings plc has 509 filings in SEC EDGAR's recent list, going back to Mar 29, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

MeiraGTx Holdings plc SEC filings
Form Description Filed Period
4 Insider transaction Oct 20, 2026 Oct 20, 2026
144 Notice of proposed sale Oct 20, 2026 —
4 Insider transaction Oct 6, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 6, 2026 —
4 Insider transaction Sep 24, 2026 Sep 23, 2026
3 Initial insider ownership Sep 24, 2026 Sep 23, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 23, 2026 Sep 22, 2026
4 Insider transaction Aug 18, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
S-8 Employee stock plan registration Aug 13, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
4 Insider transaction Jul 21, 2026 Jul 21, 2026
144 Notice of proposed sale Jul 21, 2026 —
4 Insider transaction Jul 7, 2026 Jul 7, 2026
144 Notice of proposed sale Jul 7, 2026 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure
Jul 7, 2026 Jun 30, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 19, 2026 May 19, 2026
144 Notice of proposed sale May 19, 2026 —
4 Insider transaction May 14, 2026 May 13, 2026
3 Initial insider ownership May 14, 2026 May 11, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2026 —
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 11, 2026
4/A Filing Apr 28, 2026 Jan 7, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 24, 2026 —
8-K Current report
Material agreement
Apr 24, 2026 Apr 20, 2026
4 Insider transaction Apr 23, 2026 Aug 2, 2022
4 Insider transaction Apr 21, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 21, 2026 —
424B5 Prospectus supplement Apr 16, 2026 —
8-K Current report
Material agreement
Apr 16, 2026 Apr 16, 2026
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure, Other events
Apr 16, 2026 Apr 15, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 16, 2026 Apr 16, 2026
4 Insider transaction Apr 7, 2026 Apr 7, 2026
144 Notice of proposed sale Apr 7, 2026 —
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, New debt
Mar 26, 2026 Mar 25, 2026
4 Insider transaction Mar 24, 2026 Mar 24, 2026
144 Notice of proposed sale Mar 24, 2026 —
4 Insider transaction Feb 23, 2026 Feb 21, 2026
4 Insider transaction Feb 23, 2026 Feb 21, 2026
4 Insider transaction Feb 23, 2026 Feb 21, 2026
4 Insider transaction Feb 23, 2026 Feb 21, 2026
4 Insider transaction Feb 23, 2026 Feb 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 21, 2026 Jan 17, 2026
4 Insider transaction Jan 8, 2026 Jan 7, 2026
4 Insider transaction Jan 8, 2026 Jan 7, 2026
4 Insider transaction Jan 8, 2026 Jan 7, 2026
4 Insider transaction Jan 8, 2026 Jan 7, 2026
4 Insider transaction Jan 8, 2026 Jan 7, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 2, 2026 —
4 Insider transaction Jan 2, 2026 Dec 31, 2025
8-K Current report
Material agreement
Jan 2, 2026 Dec 31, 2025
4 Insider transaction Dec 23, 2025 Dec 23, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Nov 10, 2025 Nov 7, 2025
4 Insider transaction Oct 21, 2025 Oct 21, 2025
144 Notice of proposed sale Oct 21, 2025 —
4 Insider transaction Oct 7, 2025 Oct 7, 2025
144 Notice of proposed sale Oct 7, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
4 Insider transaction Jul 22, 2025 Jul 22, 2025
144 Notice of proposed sale Jul 22, 2025 —
4 Insider transaction Jul 8, 2025 Jul 8, 2025
144 Notice of proposed sale Jul 8, 2025 —
4 Insider transaction Jul 2, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Jun 26, 2025 Jun 26, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4/A Filing Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 9, 2025 Jun 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K Current report
Regulation FD disclosure
May 9, 2025 May 9, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
4 Insider transaction Apr 22, 2025 Apr 22, 2025
144 Notice of proposed sale Apr 22, 2025 —
4 Insider transaction Apr 8, 2025 Apr 8, 2025
144 Notice of proposed sale Apr 8, 2025 —
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
8-K Current report
Material agreement, Agreement ended
Apr 4, 2025 Mar 31, 2025
S-8 Employee stock plan registration Mar 13, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Mar 13, 2025 Mar 9, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Jan 21, 2025 Jan 21, 2025
144 Notice of proposed sale Jan 21, 2025 —
4 Insider transaction Jan 16, 2025 Jan 14, 2025
4 Insider transaction Jan 16, 2025 Jan 14, 2025
4 Insider transaction Jan 16, 2025 Jan 14, 2025
4 Insider transaction Jan 16, 2025 Jan 14, 2025
4 Insider transaction Jan 16, 2025 Jan 14, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
144 Notice of proposed sale Jan 7, 2025 —
8-K Current report
Other events
Dec 9, 2024 Dec 9, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Oct 15, 2024 Oct 15, 2024
SC 13D/A Amended ownership over 5% (active) Aug 14, 2024 —
4 Insider transaction Aug 14, 2024 Aug 12, 2024
8-K Current report
Other events
Aug 13, 2024 Aug 12, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 13, 2024 —
3 Initial insider ownership Aug 13, 2024 Aug 12, 2024
424B5 Prospectus supplement Aug 12, 2024 —
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 6, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction May 30, 2024 May 28, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 6, 2024
8-K/A Amended current report
Officer or director change
Apr 16, 2024 Apr 25, 2022
4 Insider transaction Apr 8, 2024 Apr 5, 2024
10-K Annual report Mar 15, 2024 Dec 31, 2023
4 Insider transaction Mar 14, 2024 Mar 12, 2024
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
SC 13D/A Amended ownership over 5% (active) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Other events
Feb 13, 2024 Feb 13, 2024
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
4/A Filing Jan 18, 2024 Jan 7, 2024
4 Insider transaction Jan 17, 2024 Jan 14, 2024
4 Insider transaction Jan 17, 2024 Jan 14, 2024
4 Insider transaction Jan 17, 2024 Jan 14, 2024
4 Insider transaction Jan 17, 2024 Jan 14, 2024
4 Insider transaction Jan 17, 2024 Jan 14, 2024
4 Insider transaction Jan 9, 2024 Jan 7, 2024
4 Insider transaction Jan 9, 2024 Jan 7, 2024
4 Insider transaction Jan 9, 2024 Jan 7, 2024
4 Insider transaction Jan 9, 2024 Jan 7, 2024
4 Insider transaction Jan 9, 2024 Jan 7, 2024
EFFECT Filing Dec 29, 2023 —
CORRESP Letter to the SEC Dec 27, 2023 —
UPLOAD Letter from the SEC Dec 27, 2023 —
S-3 Shelf registration Dec 21, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
MGTX (Nasdaq)
Fiscal year ends
December 31
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1735438

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.